Crossmark

Critical Evaluation of Ivabradine’s Cardioprotective Potential Against Anthracycline-Induced Cardiotoxicity: A Comprehensive Review of Clinical Trials, Preclinical Studies, and Current Treatment Guidelines

Crossref DOI link: https://doi.org/10.1007/s10557-025-07813-y

Published Online: 2025-11-21

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Khan, Suleman https://orcid.org/0009-0006-6486-3093
Khan, Muhammad Imad

Shah, Asim
License Information

Text and Data Mining valid from 2025-11-21

Version of Record valid from 2025-11-21
More Information

Article History

Received: 28 October 2025

Accepted: 6 November 2025

First Online: 21 November 2025

Declarations

:

: Not applicable.

: Not applicable.

: Not applicable.

: This article was not produced by AI. Although AI tools were employed to improve professionalism and readability, the content appears not to be AI-generated because of limited reliance on the technology. The main ideas and conclusions are entirely original to the authors.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below